Link Details
- Metabolite
- HMDB0000067 (Cholesterol)
- DrugBank ID
- DB00227
- Drug Name
- Lovastatin
- Effect
- Decrease
- Biospecimen
- Blood
- P-value
- Not Available
- Beta Estimator
- Not Available
- Percent Change
- Not Available
- Pearson Correlation Coefficient
- Not Available
- Comments
- Not Available
- Hidalgo L, Zambrana JL, Blanco-Molina A, Lopez-Granados A, Concha M, Casares J, Jimenez-Perez J, Lopez-Miranda J, Perez-Jimenez F: Lovastatin versus bezafibrate for hyperlipemia treatment after heart transplantation. J Heart Lung Transplant. 1995 May-Jun;14(3):461-7. [PubMed:7654731 ]
- Yeshurun D, Abukarshin R, Elias N, Lanir A, Naschitz JE: Treatment of severe, resistant familial combined hyperlipidemia with a bezafibrate-lovastatin combination. Clin Ther. 1993 Mar-Apr;15(2):355-63. [PubMed:8519043 ]
- Perez-Jimenez F, Hidalgo L, Zambrana JL, Arizon JM, Jimenez-Pereperez JA, Concha M, Espino A, Blanco J, Valles F, Lopez-Miranda J: Comparison of lovastatin and bezafibrate on lipoprotein(a) plasma levels in cardiac transplant recipients. Am J Cardiol. 1995 Mar 15;75(8):648-50. [PubMed:7887403 ]
- Chen X, Huang D, Huang M, Zhang H, Xie M, Yu Y, Hu P: [Effects of lovastatin on plasma lipid, plasma glucose and insulin metabolism of patients with type II B hyperlipemia]. Hua Xi Yi Ke Da Xue Xue Bao. 1999 Dec;30(4):444-5, 454. [PubMed:11387965 ]
- Lea AP, McTavish D: Atorvastatin. A review of its pharmacology and therapeutic potential in the management of hyperlipidaemias. Drugs. 1997 May;53(5):828-47. [PubMed:9129869 ]